Real-world Management of COPD: Dupilumab's Role in Targeting T2 Inflammation as a Treatable Trait Miguel Jiménez-Gómez, Rocío Magdalena Díaz-Campos, Marta Padilla-Bernáldez, Cristina Almeida-Calderero, Ascensión Hernando-Sanz

Therapeutic Goals and Treatable Traits: Long-Term Trends in a Severe Asthma Population Carlos Almonacid-Sánchez, Borja G. Cosío, Andrea Trisán-Alonso, Francisco Javier Callejas-González, Carolina Cisneros, Eva Martínez-Moragón, Vicente Plaza Moral, Elisabeth Vera, José Gregorio Soto-Campos, Carlos Martínez-Rivera, Bernardino Alcazar-Navarrete, Isabel Urrutia Landa, Juan Luis García-Rivero, Alicia Padilla Galo, Francisco Álvarez-Gutierrez, Jacinto Ramos-González, José Ángel Carretero-Gracia, Inmaculada Lluch, Luis Puente, Rubén Andujar-Espinosa, Luis Pérez-de-Llano

The Future of Bronchodilators in COPD and Asthma Mario Cazzola, Paola Rogliani, Maria Gabriella Matera